Dublin, Aug. 28, 2025 (GLOBE NEWSWIRE) -- The "Small-scale Bioreactors Market Size, Share & Trends Analysis Report By Product (Reusable Bioreactors, Single-use Bioreactors), By Capacity (5 ML-100 ML, ...

Cytiva expanded its collaboration with Culture Biosciences, which specializes in cloud-connected bioreactor technology, to include both hardware commercialization and technology development. Building ...

Regulatory approval is only one marker of success for biotherapeutics. Biotherapeutics must also be commercially feasible. Too high a price tag can lead to limited availability to the targeted patient ...

Multiply Labs collaborated with these life science industry leaders to demonstrate automated cell therapy manufacturing tasks, with an emphasis on cell expansion. The results of the proof-of-concept ...

Since acquiring Cytiva from General Electric for $21.4 billion in 2019, the Danaher Corporation has laid out an ambitious expansion plan for the therapeutics developer and manufacturer. Now one of its ...

The university plays a vital role in addressing social challenges and improving quality of life. Its success is built on five dynamic institutes specializing in chemistry and biotechnology, food and ...

(MENAFN- GlobeNewsWire - Nasdaq) The global small-scale bioreactors market is projected to reach USD 2.49 billion by 2033, with a CAGR of 9.4% from 2025. COVID-19 has driven demand in cell-based drug ...